Over-The-Counter Lipitor In Our Future?
the MPR take:
Although OTC statins have not been successful in gaining FDA approval in the past, Pfizer will begin a clinical study of 1,200 individuals at U.S. pharmacies in an attempt to gain approval to market Lipitor (atorvastatin) over-the-counter. The study will support the FDA application for low-dose atorvastatin (10mg) and the primary outcome will be to evaluate patient compliance with the directions on the box that instruct users to check their LDL levels and take appropriate actions based on the test result.
READ FULL ARTICLE From Forbes